Do gliosarcomas have distinct imaging features on routine MRI?
Gliosarcoma
MRI
glioblastoma
logistic regression model
multivariate analysis
Journal
The neuroradiology journal
ISSN: 2385-1996
Titre abrégé: Neuroradiol J
Pays: United States
ID NLM: 101295103
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
pubmed:
1
5
2021
medline:
15
12
2021
entrez:
30
4
2021
Statut:
ppublish
Résumé
The aim of this study was the development and external validation of a logistic regression model to differentiate gliosarcoma (GSC) and glioblastoma multiforme (GBM) on standard MR imaging. A univariate and multivariate analysis was carried out of a logistic regression model to discriminate patients histologically diagnosed with primary GSC and an age and sex-matched group of patients with primary GBM on presurgical MRI with external validation. In total, 56 patients with GSC and 56 patients with GBM were included. Evidence of haemorrhage suggested the diagnosis of GSC, whereas cystic components and pial as well as ependymal invasion were more commonly observed in GBM patients. The logistic regression model yielded a mean area under the curve (AUC) of 0.919 on the training dataset and of 0.746 on the validation dataset. The accuracy in the validation dataset was 0.67 with a sensitivity of 0.85 and a specificity of 0.5. Although some imaging criteria suggest the diagnosis of GSC or GBM, differentiation between these two tumour entities on standard MRI alone is not feasible.
Identifiants
pubmed: 33928823
doi: 10.1177/19714009211012345
pmc: PMC8551440
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
501-508Références
J Neurosurg. 1976 Oct;45(4):398-408
pubmed: 956876
Cancer. 1991 May 1;67(9):2342-9
pubmed: 1849447
J Comput Assist Tomogr. 1996 Sep-Oct;20(5):719-23
pubmed: 8797900
J Comput Assist Tomogr. 2011 Nov-Dec;35(6):667-73
pubmed: 22082533
Neuroradiol J. 2013 Dec;26(6):639-48
pubmed: 24355182
Asian J Neurosurg. 2015 Jul-Sep;10(3):195-202
pubmed: 26396606
J Neurooncol. 2018 Apr;137(2):303-311
pubmed: 29264835
J Neurosurg. 2010 Jan;112(1):26-32
pubmed: 19408981
Eur Radiol. 2019 Jan;29(1):429-438
pubmed: 29948068
Neuro Oncol. 2009 Apr;11(2):183-91
pubmed: 18780813
J Neurooncol. 2007 May;83(1):39-46
pubmed: 17171442
Cancer Med. 2019 Oct;8(14):6233-6242
pubmed: 31464103
Cancer. 2000 May 15;88(10):2342-9
pubmed: 10820357
J Neurooncol. 2005 Aug;74(1):59-63
pubmed: 16078109
Childs Nerv Syst. 2006 Mar;22(3):314-9
pubmed: 16133270
Neuroradiol J. 2012 May;25(2):173-80
pubmed: 24028910
Cureus. 2019 Dec 15;11(12):e6384
pubmed: 31938662
Neuroradiol J. 2020 Apr;33(2):160-168
pubmed: 31957551
Cancer. 1995 Jun 15;75(12):2910-8
pubmed: 7773942
J Neurooncol. 2017 May;132(3):521-522
pubmed: 28290000
Front Oncol. 2020 Mar 11;10:337
pubmed: 32219069
Neuroradiol J. 2017 Dec;30(6):546-553
pubmed: 28644110
J Neuroimaging. 2019 Jan;29(1):126-132
pubmed: 30295979
Acta Radiol. 2008 Nov;49(9):1058-67
pubmed: 18766496
J Neurosurg. 1998 Sep;89(3):425-30
pubmed: 9724117
Brain Pathol. 2016 Jul;26(4):517-22
pubmed: 26443480
Neuroradiol J. 2021 Feb;34(1):33-41
pubmed: 33081585
Stem Cells. 2010 Feb;28(2):181-90
pubmed: 19937755
J Neurooncol. 2016 Aug;129(1):85-92
pubmed: 27169763
Sci Rep. 2019 Jul 24;9(1):10744
pubmed: 31341246
J Clin Neurosci. 2014 Mar;21(3):478-81
pubmed: 24332268
Front Oncol. 2019 Dec 17;9:1425
pubmed: 31921679